BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31127282)

  • 1. Acute depletion of CTCF directly affects MYC regulation through loss of enhancer-promoter looping.
    Hyle J; Zhang Y; Wright S; Xu B; Shao Y; Easton J; Tian L; Feng R; Xu P; Li C
    Nucleic Acids Res; 2019 Jul; 47(13):6699-6713. PubMed ID: 31127282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia.
    Luo H; Zhu G; Eshelman MA; Fung TK; Lai Q; Wang F; Zeisig BB; Lesperance J; Ma X; Chen S; Cesari N; Cogle C; Chen B; Xu B; Yang FC; So CWE; Qiu Y; Xu M; Huang S
    Mol Cell; 2022 Feb; 82(4):833-851.e11. PubMed ID: 35180428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.
    Ottema S; Mulet-Lazaro R; Erpelinck-Verschueren C; van Herk S; Havermans M; Arricibita Varea A; Vermeulen M; Beverloo HB; Gröschel S; Haferlach T; Haferlach C; J Wouters B; Bindels E; Smeenk L; Delwel R
    Nat Commun; 2021 Sep; 12(1):5679. PubMed ID: 34584081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
    Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
    Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
    Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
    Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
    Kang J; Kim YW; Park S; Kang Y; Kim A
    FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
    Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia.
    Kloetgen A; Thandapani P; Ntziachristos P; Ghebrechristos Y; Nomikou S; Lazaris C; Chen X; Hu H; Bakogianni S; Wang J; Fu Y; Boccalatte F; Zhong H; Paietta E; Trimarchi T; Zhu Y; Van Vlierberghe P; Inghirami GG; Lionnet T; Aifantis I; Tsirigos A
    Nat Genet; 2020 Apr; 52(4):388-400. PubMed ID: 32203470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute depletion of CTCF rewires genome-wide chromatin accessibility.
    Xu B; Wang H; Wright S; Hyle J; Zhang Y; Shao Y; Niu M; Fan Y; Rosikiewicz W; Djekidel MN; Peng J; Lu R; Li C
    Genome Biol; 2021 Aug; 22(1):244. PubMed ID: 34429148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTCF knockout in zebrafish induces alterations in regulatory landscapes and developmental gene expression.
    Franke M; De la Calle-Mustienes E; Neto A; Almuedo-Castillo M; Irastorza-Azcarate I; Acemel RD; Tena JJ; Santos-Pereira JM; Gómez-Skarmeta JL
    Nat Commun; 2021 Sep; 12(1):5415. PubMed ID: 34518536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
    Wu Y; Jia Z; Ge X; Wu Q
    Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin alternates between A and B compartments at kilobase scale for subgenic organization.
    Harris HL; Gu H; Olshansky M; Wang A; Farabella I; Eliaz Y; Kalluchi A; Krishna A; Jacobs M; Cauer G; Pham M; Rao SSP; Dudchenko O; Omer A; Mohajeri K; Kim S; Nichols MH; Davis ES; Gkountaroulis D; Udupa D; Aiden AP; Corces VG; Phanstiel DH; Noble WS; Nir G; Di Pierro M; Seo JS; Talkowski ME; Aiden EL; Rowley MJ
    Nat Commun; 2023 Jun; 14(1):3303. PubMed ID: 37280210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outward-oriented sites within clustered CTCF boundaries are key for intra-TAD chromatin interactions and gene regulation.
    Ge X; Huang H; Han K; Xu W; Wang Z; Wu Q
    Nat Commun; 2023 Dec; 14(1):8101. PubMed ID: 38062010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.
    Xiang JF; Yin QF; Chen T; Zhang Y; Zhang XO; Wu Z; Zhang S; Wang HB; Ge J; Lu X; Yang L; Chen LL
    Cell Res; 2014 May; 24(5):513-31. PubMed ID: 24662484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.
    Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
    Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
    Eldholm V; Haugen A; Zienolddiny S
    Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
    Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC reshapes CTCF-mediated chromatin architecture in prostate cancer.
    Wei Z; Wang S; Xu Y; Wang W; Soares F; Ahmed M; Su P; Wang T; Orouji E; Xu X; Zeng Y; Chen S; Liu X; Jia T; Liu Z; Du L; Wang Y; Chen S; Wang C; He HH; Guo H
    Nat Commun; 2023 Mar; 14(1):1787. PubMed ID: 36997534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism.
    Schuijers J; Manteiga JC; Weintraub AS; Day DS; Zamudio AV; Hnisz D; Lee TI; Young RA
    Cell Rep; 2018 Apr; 23(2):349-360. PubMed ID: 29641996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human β-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites.
    Kim J; Kang J; Kim YW; Kim A
    FASEB J; 2021 Jun; 35(6):e21669. PubMed ID: 34033138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.